Vestal Point Capital, LP

Position in SVRA — Savara Inc

CIK 1974915 NEW YORK, NY

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,196,283

+$4,512,103 QoQ

Shares Held

2,600,052

+61.9% QoQ

Ownership

1.27%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#20

of 184 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $2,697,459,670 across 67 Biotechnology names. SVRA ranks #43 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,375,000	$230,968,750
2	BMRN	Biomarin Pharmaceutical Inc	3,575,000	$201,951,750
3	ABVX	Abivax S.A.	1,500,000	$167,025,000
4	ARWR	Arrowhead Pharmaceuticals, Inc.	2,275,000	$142,642,500
5	ELVN	Enliven Therapeutics, Inc.	3,250,000	$127,400,000
6	BCAX	Bicara Therapeutics Inc.	5,425,000	$107,903,250
7	NRIX	Nurix Therapeutics, Inc.	6,500,000	$100,750,000
8	APGE	Apogee Therapeutics, Inc.	1,100,000	$92,587,000

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,196,283	2,600,052	+61.9%	Shares	Sole	2026-05-15
2025-12-31	$9,684,180	1,606,000	-60.0%	Shares	Sole	2026-02-17
2025-09-30	$14,333,550	4,015,000	-63.5%	Shares	Sole	2025-11-14
2025-06-30	$25,114,200	11,015,000	+0.1%	Shares	Sole	2025-08-14
2025-03-31	$30,470,000	11,000,000	+2.1%	Shares	Sole	2025-05-15
2024-12-31	$33,079,250	10,775,000	+33.2%	Shares	Sole	2025-02-14
2024-09-30	$34,301,600	8,090,000	+24.7%	Shares	Sole	2024-11-14
2024-06-30	$26,154,700	6,490,000	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.